Screening of siRNA target sequences by using fragmentized DNA
- PMID: 16532512
- DOI: 10.1002/jgm.900
Screening of siRNA target sequences by using fragmentized DNA
Abstract
Background: RNA interference (RNAi) has become a powerful tool in silencing target genes in various organisms. In mammals, RNAi can be induced by using short interfering RNA (siRNA). The efficacy of inducing RNAi in mammalian cells by using siRNA depends very much on the selection of the target sequences.
Methods: We developed an siRNA target sequence selection system by first constructing parallel-type siRNA expression vector libraries carrying siRNA expression fragments originating from fragmentized target genes, and then using a group selection system. For a model system, we constructed parallel-type siRNA expression vector libraries against DsRed and GFP reporter genes.
Results: We carried out the first screening of groups containing more than 100 random siRNA expression plasmids in total for each target gene, and successfully obtained target sequences with very strong efficacy. Furthermore, we also obtained some clones that express dsRNAs of various lengths that might induce cytotoxicity.
Conclusions: This system should allow us to perform screening for powerful target sequences, by including all possible target sequences for any gene, even without knowing the whole sequence of the target gene in advance. At the same time, target sequences that should be avoided due to cytotoxicity can be identified.
Copyright 2006 John Wiley & Sons, Ltd.
Similar articles
-
A plasmid-based system for expressing small interfering RNA libraries in mammalian cells.BMC Cell Biol. 2004 Apr 30;5:16. doi: 10.1186/1471-2121-5-16. BMC Cell Biol. 2004. PMID: 15119963 Free PMC article.
-
Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.Gene. 2007 Jun 15;395(1-2):160-9. doi: 10.1016/j.gene.2007.02.030. Epub 2007 Mar 23. Gene. 2007. PMID: 17449199
-
Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.J Biotechnol. 2005 Nov 21;120(3):251-61. doi: 10.1016/j.jbiotec.2005.06.014. Epub 2005 Aug 10. J Biotechnol. 2005. PMID: 16095743
-
Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):164-82. doi: 10.1016/j.addr.2007.03.010. Epub 2007 Mar 21. Adv Drug Deliv Rev. 2007. PMID: 17481774 Review.
-
Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.Adv Drug Deliv Rev. 2009 Jul 25;61(9):760-6. doi: 10.1016/j.addr.2009.04.006. Epub 2009 Apr 20. Adv Drug Deliv Rev. 2009. PMID: 19386274 Review.
Cited by
-
Development of a siRNA and shRNA screening system based on a kinase fusion protein.RNA. 2012 Jun;18(6):1296-306. doi: 10.1261/rna.030015.111. Epub 2012 Apr 26. RNA. 2012. PMID: 22539522 Free PMC article.
-
Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts.J Bone Miner Metab. 2013 Jul;31(4):409-16. doi: 10.1007/s00774-013-0434-0. Epub 2013 Mar 24. J Bone Miner Metab. 2013. PMID: 23525827
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources